FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
05/21/2026
Back to search
Official data from USPTO
CUREGENE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
05/22/2026
Trademark type
Word
Nice classes
5
Filing date
07/05/2022
Registration date
10/28/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/28/2025
Last transaction
05/22/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
CN
Examiner
DAVIS, MARC STEPHEN
Law office
N40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Nanjing Curegene Technology Co., Ltd.
Representatives
Prakash NAMA
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Immunostimulants; chemical preparations for medical purposesfor gene therapy purpose; veterinary preparationsantioxidants; diagnostic preparations for veterinary purposes; enzyme preparations for veterinary purposes; amino acid preparations for medical purposes; chemical preparations for medical purposespreparations of trace elements for human and animal useas a nutritional supplement; diagnostic preparations for medical purposes; reagents for use in veterinary genetic testing; vaccine preparations; diagnostic biomarker reagents for medical purposes; reagents for use in medical genetic testing; biological tissue cultures for medical purposes; enzyme preparations for medical purposes; cultures of microorganisms for medical or veterinary use
Publications
History of USPTO decisions and trademark events.
34 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/01/2026
FIMP
FINAL DISPOSITION PROCESSED
05/01/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/28/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/28/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
10/28/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/09/2025
PUBO
PUBLISHED FOR OPPOSITION
09/09/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/03/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/08/2025
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
08/02/2025
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
02/01/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
07/07/2024
GNSL
LETTER OF SUSPENSION E-MAILED
07/07/2024
CNSL
SUSPENSION LETTER WRITTEN
07/07/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/11/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/21/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
02/21/2024
GRML
CORRESPONDENCE E-MAILED
12/15/2023
CNSL
SUSPENSION LETTER WRITTEN
12/15/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/15/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/15/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/15/2023
RFNP
REFUSAL PROCESSED BY IB
07/22/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/21/2023
RFRR
REFUSAL PROCESSED BY MPU
06/20/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/12/2023
CNRT
NON-FINAL ACTION WRITTEN
05/11/2023
DOCK
ASSIGNED TO EXAMINER
04/19/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/15/2022
MAFR
APPLICATION FILING RECEIPT MAILED
09/23/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/19/2022
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
09/18/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/15/2022
Continuous trademark protection
Get notified about every new filing that threatens CUREGENE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.